Innocan Pharma Corp (INNO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 12 | 11 | 9 | 10 | 6 |
| Income taxes - deferred | -262 | N/A | N/A | N/A | N/A |
| Accounts receivable | 0 | -754 | 288 | 466 | 0 |
| Accounts payable and accrued liabilities | 192 | -190 | 55 | -7 | 52 |
| Other Working Capital | 1,099 | -907 | 891 | 489 | 48 |
| Other Operating Activity | -1,622 | 1,862 | -557 | -590 | -610 |
| Operating Cash Flow | $-581 | $22 | $686 | $368 | $-504 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -4 | -1 | -5 | -4 |
| Other Investing Activity | 1 | 0 | -1 | 1 | 69 |
| Investing Cash Flow | $-5 | $-4 | $-2 | $-4 | $65 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 0 | 640 | N/A |
| Debt Repayment | 0 | -3 | -4 | -4 | -6 |
| Common Stock Issued | 0 | 0 | 93 | 0 | -123 |
| Other Financing Activity | 0 | 0 | 64 | 360 | 529 |
| Financing Cash Flow | $0 | $-3 | $153 | $996 | $400 |
| Exchange Rate Effect | 3 | 0 | 53 | -3 | -10 |
| Beginning Cash Position | 7,270 | 7,255 | 6,365 | 5,008 | 5,057 |
| End Cash Position | 6,687 | 7,270 | 7,255 | 6,365 | 5,008 |
| Net Cash Flow | $-586 | $15 | $837 | $1,360 | $-39 |
| Free Cash Flow | |||||
| Operating Cash Flow | -581 | 22 | 686 | 368 | -504 |
| Capital Expenditure | -6 | -4 | -1 | -5 | -4 |
| Free Cash Flow | -587 | 18 | 685 | 363 | -508 |